An interventional study of Clinical Improvisation in Alzheimer's Disease (AD) and Older Adults (65 Years and Older), sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-23.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Alzheimer Disease by University of California, San Francisco — 3 open to participants now, 5 under way, none of them phase 3. Alzheimer Disease · University of California, San Francisco.
Among the 17 studies in Alzheimer Disease by University of California, San Francisco, this one is the 9th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2026, is one of 13 with no phase, and was the 16th registered.
3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.
Browse Alzheimer Disease studies →3 of the 17 studies in Alzheimer Disease by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:
University of California, San Francisco · Sites in United States
Ages 65+
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.
This study: 60 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 70 across 3,022 interventional studies indexed under Alzheimer Disease.
Median enrollment 66 across the 15 interventional studies, 100,030 across the 2 observational. Of the 11 that completed or were terminated, 7 (64%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.
Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Alzheimer Disease by University of California, San Francisco, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Older adults and their care partners will participate in music therapy sessions for approximately 8 weeks. Before and after the 8 week study period, participants will fill out questionnaires about their mood, stress levels, and emotions. During the music therapy sessions, they may be observed or asked questions about the music therapy sessions.
Inclusion Criteria
Inclusion criteria for the Person Living with Dementia (PLWD) are:
Inclusion Criteria for Caregiver are:
Exclusion Criteria
Exclusion criteria for PLWD are:
Exclusion criteria for Caregiver are:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinical Improvisation Immediately
Behavioral: Clinical Improvisation
Delayed Onset Clinical improvisation
Behavioral: Clinical Improvisation
Clinical improvisation music therapy offered as group sessions delivered by board-certified music therapist.
Science of Behavior Change (SOBC) Brief-COPE
The Brief COPE is a 28 item measure of strategies used for coping or regulating cognitions in response to stressors. The questions assess the frequency with which a person uses different coping strategies (e.g. "I've been turning to work or other activities to take my mind off strings") and the respondent gives a rating on a 5 item scale (1= I haven't been doing this at all to 4 I've been doing this a lot).
Time frame: Baseline and Post-Intervention, 8 weeks
SOBC Perceived Stress Scale
The Perceived Stress Scale ask participants about their feelings and thoughts during the last month. There are 10 items and participants are asked how often they felt orr thought a certian way (0 = never to 4 very often)
Time frame: Baseline and Post Intervention, 8 weeks
Dementia Mood Picture Test
Participants are given large line face drawings with large font descriptors. Participants are asked whether or not they are experiencing each mood ("Are you in a good mood?") and the intensity of the mood. The test assesses the PLWD directly but focuses on six primary moods.
Time frame: Baseline and Post Intervention, 8 weeks
SOBC Positive and Negative Affect (PANAS)
The PANAS is a 20 item self-questionnaire. Respondent is asked to read several words which describe different feelings and emotions. Applicability of the emotion is scored by respondent on a 5 point Likert Scale (1 = very slightly or not at all to 5 = extremely). Higher scores on Positive Affect items incidate greater intensity of positive emotions and higher scores on Negative Affect indicate greater intensity of negative emotions.
Time frame: Baseline and Post Intervention, 8 weeks
Neuropsychiatric Inventory (NPI-Q)
The NPI-Q is a 12-item questionnaire completed by the caregiver. Each question asks about a neuropsychiatric symptom over the previous month. The Caregiver can say "no" and go on to the next question. If the Caregiver says "yes", the caregive then rates the a) Severity of the symptoms present on a 3 point scale (1=mild to 3 = severe), and b) Distress experienced by the caregiver due to that symptom on a 5 point scale (0 = not distressing at all to 5 very distressing).
Time frame: Baseline and Post Intervention, 8 weeks
Kingston Caregivers STress Scale
The KCSS is at 10 item questionnaire completed by a family caregiver. The questions ask caregivers to report feeling of stress surrounding specific aspects of caregiving. Caregivers respond using a 5 point scale (1 = no stress to 5 = extreme stress)
Time frame: Baseline and Post-Intervention, 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2028, 24 months later.
Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 24 months is below that.
Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →